Author

Mark W. Surber

Observed names: Mark Surber, Mark W Surber

Institution: Vaxiion Therapeutics (United States)

Observed institutions: University of Illinois Urbana-Champaign, Vaxiion Therapeutics (United States)

OpenAlex ID: A5079745319

Toxic Protein Expression in Escherichia Coli Using a Rhamnose-Based Tightly Regulated and Tunable Promoter System

2006 · Matthew J. Giacalone, Angela M. Gentile, et al. · BioTechniques · 177

Type II protein secretion by Pseudomonas aeruginosa: genetic suppression of a conditional mutation in the pilin‐like component XcpT by the cytoplasmic component XcpR

1998 · Yoshihiro Kagami, Melanie Ratliff, et al. · Molecular Microbiology · 72

The PutA Protein ofSalmonella typhimuriumCatalyzes the Two Steps of Proline Degradation via a Leaky Channel

1998 · Mark W. Surber, Stanley Maloy · Archives of Biochemistry and Biophysics · 36

Regulation of flavin dehydrogenase compartmentalization: requirements for PutA–membrane association in Salmonella typhimurium

1999 · Mark W Surber, Stanley Maloy · Biochimica et Biophysica Acta (BBA) - Biomembranes · 35

The use of bacterial minicells to transfer plasmid DNA to eukaryotic cells

2006 · Matthew J. Giacalone, Angela M. Gentile, et al. · Cellular Microbiology · 16

Corrigendum to “Immune responses elicited by bacterial minicells capable of simultaneous DNA and protein antigen delivery” [Vaccine 2006;24(33–34):6009–6017]

2007 · Matthew J. Giacalone, Roger A. Sabbadini, et al. · Vaccine

Proline Utilization in Salmonella Typhimurium: A Model for Regulation of Peripheral-Membrane Flavin Dehydrogenase-Lipid Interactions

1999 · Mark W. Surber · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)

Works count: 7

Citation count: 336

H-index: 5

I10-index: 5